Novel agent reactivates an immune call by LIF blockade: Promising new therapy with a dual mechanism of action to eliminate cancer stem cells and activate the immune system now in clinical development

Results from a study spearhead by researchers at the Vall d´Hebron Institute of Oncology (VHIO), show that the blockade of […]
» Read more